The following information was accurate at the time of posting, but may be superseded by subsequent disclosure.
December 10, 2007
Tekmira’s Partner Hana Presents Marqibo® Data at American Society of Hematology Meeting
November 21, 2007
Tekmira Provides Update on Partners Clinical Progress
November 14, 2007
Tekmira Release Third Quarter 2007 Operating Results
November 13, 2007
Tekmira Conference Call Advisory; 2007 Third Quarter Operating Results
November 8, 2007
1322256 Alberta Ltd. (formerly Inex) Announces Closing of Private Placement
October 23, 2007
Tekmira Partner Hana Achieves Clinical Progress in 2007
October 16, 2007
Tekmira Provides Update on Ongoing Legal Dispute with Protiva
August 8, 2007
Tekmira Releases Second Quarter 2007 Operating Results
August 3, 2007
Tekmira Partner Begins Phase 2 Clinical Trial for Marqibo®
August 2, 2007
Tekmira Conference Call Advisory - 2007 Second Quarter Operating Results
July 09, 2007
Tekmira Comments on Market Activity
June 20, 2007
Tekmira Provides Operational Update at AGM
May 15, 2007
Tekmira Releases First Quarter 2007 Operating Results
May 10, 2007
Tekmira Conference Call Advisory - 2007 First Quarter Operating Results
May 01, 2007
INEX Announces Completion of Spin-out of Tekmira
April 26, 2007
INEX Announces Expected Completion Date for Spin-out of Tekmira
April 17, 2007
INEX Provides Progress Update on Alnylam Collaboration
March 30, 2007
INEX Extends Timeline for Completing Spin-out of Tekmira
March 21, 2007
INEX Releases 2006 Operating Results
March 20, 2007
INEX Conference Call Advisory
March 07, 2007
INEX and Alnylam Announce Allowance of New U.S. Patent
February 26, 2007
INEX Provides Timeline for Completing Tekmira Spin-out
February 23, 2007
INEX Submits Petition Against Protiva
February 20, 2007
INEX Closes Bought Deal Financing
February 06, 2007
INEX Announces Court of Appeal Win
January 30, 2007
INEX Announces $13,950,000 Bought Deal
January 15, 2007
INEX Announces Appeal Date for Spin-out of Tekmira
January 09, 2007
Alnylam and Inex Form Strategic Alliance